Vir CFO O’Byrne joining Olema

Jason O’Byrne has joined breast cancer company  Olema Pharmaceuticals Inc. (NASDAQ:OLMA) as CFO from Vir Biotechnology Inc. (NASDAQ:VIR), where he held the same role. O’Byrne was also CFO of Caribou Biosciences Inc. (NASDAQ:CRBU) and SVP of Finance at Astellas Pharma Inc. (Tokyo:4503)...